News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis AG Vaccine Shields Against Meningitis Cause


6/9/2011 7:42:50 AM

Novartis AG's (NOVN.VX) Bexsero vaccine helps protect toddlers against the most common cause of meningitis when used as a booster, the Swiss drugmaker said on Thursday, giving its meningitis franchise another lift. A late-stage study showed toddlers who had three doses as infants were protected against the meningococcal serogroup B, or MenB, when later given extra doses, cutting their risk of catching the potentially deadly illness.

Read at BioSpace.com
Read at RTT News
Read at News Release
Read at Medical News Today
Read at Reuters


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES